litlas
ログインアカウント作成

Charles V. Pollack

1994–2025 年に発表

99
論文数
18,877
被引用数
79
h 指数
98
i10 指数

被引用数

Charles V. Pollack の年別被引用数1952 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 3 件1997 年: 被引用 2 件1998 年: 被引用 2 件1999 年: 被引用 5 件2000 年: 被引用 10 件2001 年: 被引用 13 件2002 年: 被引用 12 件2003 年: 被引用 20 件2004 年: 被引用 25 件2005 年: 被引用 60 件2006 年: 被引用 84 件2007 年: 被引用 122 件2008 年: 被引用 107 件2009 年: 被引用 110 件2010 年: 被引用 151 件2011 年: 被引用 132 件2012 年: 被引用 131 件2013 年: 被引用 101 件2014 年: 被引用 129 件2015 年: 被引用 129 件2016 年: 被引用 134 件2017 年: 被引用 128 件2018 年: 被引用 118 件2019 年: 被引用 425 件2020 年: 被引用 386 件2021 年: 被引用 321 件2022 年: 被引用 206 件2023 年: 被引用 157 件2024 年: 被引用 288 件2025 年: 被引用 110 件2026 年: 被引用 6 件1953〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,466 件、この内訳の 26.5%イギリス: 引用元論文 461 件、この内訳の 8.3%カナダ: 引用元論文 332 件、この内訳の 6%ドイツ: 引用元論文 287 件、この内訳の 5.2%イタリア: 引用元論文 281 件、この内訳の 5.1%フランス: 引用元論文 263 件、この内訳の 4.8%オーストラリア: 引用元論文 192 件、この内訳の 3.5%オランダ: 引用元論文 189 件、この内訳の 3.4%スペイン: 引用元論文 170 件、この内訳の 3.1%中国: 引用元論文 168 件、この内訳の 3%スウェーデン: 引用元論文 155 件、この内訳の 2.8%スイス: 引用元論文 133 件、この内訳の 2.4%
0%26.5%その他 25.9%

機関

分野

  • Medicine90.9%
  • Biochemistry, Genetics and Molecular Biology2.5%
  • Health Professions1.5%
  • Engineering0.9%
  • Economics, Econometrics and Finance0.7%
  • Environmental Science0.5%
  • その他3%

トピック

  • Acute Myocardial Infarction Research10.1%
  • Atrial Fibrillation Management and Outcomes6.5%
  • Antiplatelet Therapy and Cardiovascular Diseases5%
  • Venous Thromboembolism Diagnosis and Management5%
  • Cardiac Imaging and Diagnostics4.1%
  • Coronary Interventions and Diagnostics3.5%
  • その他65.8%

共著者

全論文

検索で開く
  1. Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    著者: Charles V. Pollack, Paul Reilly, Joanne van Ryn, John W. Eikelboom, Stephan Glund, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, CW Kam, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Gordon Royle, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Peter Verhamme, Bushi Wang, Laura Young, Jeffrey I. Weitz - New England Journal of Medicine 2017 被引用: 1,136

  2. Idarucizumab for Dabigatran Reversal

    著者: Charles V. Pollack, Paul A. Reilly, John W. Eikelboom, Stephan Glund, Peter Verhamme, Richard A. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, Jörg Kreuzer, Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, CW Kam, Jeffrey I. Weitz - New England Journal of Medicine 2015 被引用: 1,454

  3. Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department

    著者: Charles V. Pollack, Donald Schreiber, Samuel Z. Goldhaber, David Slattery, John Fanikos, Brian J. O’Neil, James Thompson, Brian Hiestand, Beau Briese, Robert C. Pendleton, Chadwick D. Miller, Jeffrey A. Kline - Journal of the American College of Cardiology 2011 被引用: 542

  4. Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction

    著者: Sumeet Subherwal, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, L. Kristin Newby, Tracy Y. Wang, W. Brian Gibler, E. Magnus Ohman, Matthew T. Roe, Charles V. Pollack, Eric D. Peterson, Karen P. Alexander - Circulation 2009 被引用: 991

  5. Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    著者: Robert A. Harrington, Gregg W. Stone, Steven E. McNulty, Harvey D. White, A. Michael Lincoff, C. Michael Gibson, Charles V. Pollack, Gilles Montalescot, Kenneth W. Mahaffey, Neal S. Kleiman, Shaun G. Goodman, Maged Amine, Dominick J. Angiolillo, Richard C. Becker, Derek P. Chew, William J. French, F Leisch, Keyur Parikh, Simona Skerjanec, Deepak L. Bhatt - New England Journal of Medicine 2009 被引用: 618

  6. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

    著者: Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, Eva Lesén, Abiy Agiro, Matthew Arnold, Gengshi Chen, Toshitaka Yajima, Krister Järbrink, Charles V. Pollack - BMC Nephrology 2023 被引用: 51

  7. Intravenous Platelet Blockade with Cangrelor during PCI

    著者: Deepak L. Bhatt, A. Michael Lincoff, C. Michael Gibson, Gregg W. Stone, Steven E. McNulty, Gilles Montalescot, Neal S. Kleiman, Shaun G. Goodman, Harvey D. White, Kenneth W. Mahaffey, Charles V. Pollack, Steven V. Manoukian, Petr Widimský, Derek P. Chew, Fernando Cura, Ivan H Manukov, František Toušek, M. Zubair Jafar, Jaspal Arneja, Simona Skerjanec, Robert A. Harrington - New England Journal of Medicine 2009 被引用: 643

  8. Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

    著者: Deepak L. Bhatt, Charles V. Pollack, Jeffrey I. Weitz, Lisa K. Jennings, Sherry L. Xu, Susan Arnold, Bret R. Umstead, Michael C. Mays, John S. Lee - New England Journal of Medicine 2019 被引用: 135

  9. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

    著者: Gilles Montalescot, Uwe Zeymer, Johanne Silvain, Bertrand Boulanger, Marc Cohen, Patrick Goldstein, Patrick Ecollan, X. Combes, Kurt Huber, Charles V. Pollack, Jean-François Bénezet, Olivier Stibbe, Emmanuelle Filippi, Emmanuel Teíger, Guillaume Cayla, Simon Elhadad, Frédéric Adnet, Tahar Chouihed, S. Gallula, Agnès Greffet, Mounir Aout, Jean‐Philippe Collet, Éric Vicaut - The Lancet 2011 被引用: 322

  10. Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial

    著者: Michael D. Ezekowitz, Charles V. Pollack, Jonathan L. Halperin, Richard D. England, Sandra VanPelt Nguyen, Judith Spahr, Maria Sudworth, Nilo B. Cater, Andrei Breazna, Jonas Oldgren, Paulus Kirchhof - European Heart Journal 2018 被引用: 172

  11. 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

    著者: Gordon F. Tomaselli, Kenneth W. Mahaffey, Adam Cuker, Paul P. Dobesh, John Doherty, John W. Eikelboom, Roberta Florido, William J. Hucker, Roxana Mehran, Steven R. Messé, Charles V. Pollack, Fátima Rodríguez, Ravi Sarode, Deborah Siegal, Barbara S. Wiggins - Journal of the American College of Cardiology 2017 被引用: 347

  12. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis

    著者: Johanne Silvain, Farzin Beygui, Olivier Barthélémy, Charles V. Pollack, Mauricio G. Cohen, Uwe Zeymer, Kurt Huber, Patrick Goldstein, Guillaume Cayla, Jean Collet, Éric Vicaut, Gilles Montalescot - BMJ 2012 被引用: 221

  13. EP-7041, a Factor XIa Inhibitor as a Potential Antithrombotic Strategy in Extracorporeal Membrane Oxygenation: A Brief Report

    著者: Charles V. Pollack, Michael A. Kurz, Neil J. Hayward - Critical Care Explorations 2020 被引用: 44

  14. Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction

    著者: John G. Canto, Catarina I. Kiefe, William J. Rogers, Eric D. Peterson, Paul D. Frederick, William J. French, C. Michael Gibson, Charles V. Pollack, Joseph P. Ornato, Robert J. Zalenski, Jan Penney, Alan J. Tiefenbrunn, Philip Greenland, for the NRMI Investigators - JAMA 2011 被引用: 261

  15. Developing a Decision Instrument to Guide Computed Tomographic Imaging of Blunt Head Injury Patients

    著者: William R. Mower, Jerome R. Hoffman, Mel Herbert, Allan B. Wolfson, Charles V. Pollack, Michael I. Zucker - The Journal of Trauma: Injury, The Journal of Trauma: Injury, Infection, and Critical Care 2005 被引用: 209

  16. Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs

    著者: Nicholas Cooney, Charles V. Pollack, Paul Butkerait - Therapeutics and Clinical Risk Management 2015 被引用: 208

  17. Frequency and Consequences of Recording an Electrocardiogram >10 Minutes After Arrival in an Emergency Room in Non–ST-Segment Elevation Acute Coronary Syndromes (from the CRUSADE Initiative)

    著者: Deborah B. Diercks, W. Frank Peacock, Brian Hiestand, Anita Y. Chen, Charles V. Pollack, J. Douglas Kirk, Sidney C. Smith, W. Brian Gibler, E. Magnus Ohman, Andra L. Blomkalns, L. Kristin Newby, Judith S. Hochman, Eric D. Peterson, Matthew T. Roe - The American Journal of Cardiology 2005 被引用: 119

  18. Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery

    著者: Deepak L. Bhatt, Charles V. Pollack, C. David Mazer, Dominick J. Angiolillo, Philippe Gabríel Steg, Stefan James, Jeffrey I. Weitz, Rohit Ramnath, Susan Arnold, Michael C. Mays, Bret R. Umstead, Barbara White, Lisa Hickey, Lisa K. Jennings, Benjamin J. Curry, John S. Lee, Subodh Verma - NEJM Evidence 2021 被引用: 56

  19. Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding

    著者: Sake J. van der Wall, Renato D. Lópes, James Aisenberg, Paul A. Reilly, Joanne van Ryn, Stephan Glund, Amelie Elsaesser, Frederikus A. Klok, Charles V. Pollack, Menno V. Huisman - Circulation 2019 被引用: 48

  20. Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel

    著者: Christopher W. Baugh, Michael P. Levine, David Cornutt, Jason Wilson, Richard Kwun, Charles E. Mahan, Charles V. Pollack, Evie G. Marcolini, Truman J. Milling, W. Frank Peacock, Rachel Rosovsky, Fred Wu, Ravi Sarode, Alex C. Spyropoulos, Todd C. Villines, Timothy Woods, John McManus, James M. Williams - Annals of Emergency Medicine 2019 被引用: 91

  21. Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study

    著者: Abiy Agiro, Amin AN, Erin Cook, Fan Mu, Jingyi Chen, Pooja Desai, Yemmie Oluwatosin, Charles V. Pollack - Advances in Therapy 2023 被引用: 25

  22. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes

    著者: Deepak L. Bhatt, Eric D. Peterson, Robert A. Harrington, Fang‐Shu Ou, Christopher P. Cannon, C. Michael Gibson, Neal S. Kleiman, Ralph G. Brindis, W. Frank Peacock, S. Brener, Venu Menon, Sidney C. Smith, Charles V. Pollack, W. Brian Gibler, E. Magnus Ohman, M. T. Roe, for the CRUSADE Investigators - European Heart Journal 2009 被引用: 199

  23. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006

    著者: William J. Rogers, Paul D. Frederick, Edna Stoehr, John G. Canto, Joseph P. Ornato, C. Michael Gibson, Charles V. Pollack, Joel M. Gore, Nisha Chandra‐Strobos, Eric D. Peterson, William J. French - American Heart Journal 2008 被引用: 421

  24. Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative

    著者: Trip J. Meine, Matthew T. Roe, Anita Y. Chen, Manesh R. Patel, Jeffrey B. Washam, E. Magnus Ohman, W. Frank Peacock, Charles V. Pollack, W. Brian Gibler, Eric D. Peterson - American Heart Journal 2005 被引用: 307